Seattle Genetics Wants To Premiere Twelve New Drugs with the help of Clay Siegall

There are a lot of smaller drug companies on the market that people might have heard of unless they are in treatment, and it is important that they all have a much better place to search for cancer medication. Clay Siegall leads the company he started at Seattle Genetics with his cancer drugs that help people with breast cancer and lymphoma, but he is now looking to premiere twelve new drugs.

The twelve new drugs that are going to come from Seattle Genetics will be paid for with the profits that they have seen from the drugs they already have. They sold $100 million in a year in their trial drugs, and they will be able to use the money to get twelve new drugs out that will help more people. Seattle Genetics is doing extremely well today, but that does not mean that they are going to be able to keep producing just two drugs and be healthy.

They want to reach more doctors who have needs for their patients, and they also want to make sure that they are going to have patients who can say that they survived because of Seattle Genetics. There are many things that can be done with more research, and the company plans to continue its research because they know that they will be able to unlock more types of cancer that are already very scary. It is very easy to learn a lot about cancer, and there are many doctors who want to join the trials.

Clay Siegall has proven to be a genius whose antibody drugs are perfect. They have sold millions, and they will continue to heal those whoa re sick. The company can parlay its profits into something that is truly powerful in the form of twelve new drugs.

Read more here: